Impact of COVID-19 public health measures and lockdown on maternal and neonatal health

  • Funded by Canadian Institutes of Health Research (CIHR)
  • Total publications:0 publications

Grant number: 474531

Grant search

Key facts

  • Disease

    COVID-19
  • start year

    2022
  • Known Financial Commitments (USD)

    $110,119.22
  • Funder

    Canadian Institutes of Health Research (CIHR)
  • Principal Investigator

    Aboulatta Laila
  • Research Location

    Canada
  • Lead Research Institution

    University of Manitoba
  • Research Priority Alignment

    N/A
  • Research Category

    Secondary impacts of disease, response & control measures

  • Research Subcategory

    Indirect health impacts

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Not applicable

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

The COVID-19 pandemic has brought exceptional challenges to global health. In Canada, a lockdown strategy was announced in March 2020 as a plan to control the spread of the novel coronavirus. However, there is an increasing concern that the pandemic lockdown might have negatively affected health services and patient outcomes, including mother and infant health. In many instances, the decreased access to health services created sub-optimal mother and infant care. In fact, primary studies show that pregnancy adverse outcomes, such as stillbirth, may have increased during the pandemic, merely due to the lockdown effects. Despite the increasing evidence of the negative effects of COVID-19 infection on pregnant women, studies evaluating the effects of the pandemic restrictions on pregnant women and newborns have shown conflicting results. My project has several goals that target this knowledge gap. First, we aim to compare the pregnancy outcomes occurring before and during the pandemic, focusing on the major pregnancy and newborn outcomes. Second, we will examine major medication classes used among pregnant women pre- and during the COVID-19 period. Third, we will examine the adequacy of health care received by pregnant women during this stressful period. We will use real-world data of linked mother-infant records from over 70,000 pregnancies to highlight the impact of pandemic restrictions on mothers and infants in Manitoba. Our studies can provide evidence to improve mother and infant's health care and prevent negative outcomes during future waves and pandemics.